| Financial Year |
March 31 2023 |
| Monetary Funds |
344,106,834.74 |
| Held-for-trading Financial Assets |
152,464,146.87 |
| Notes Receivable |
145,431,156.01 |
| Accounts Receivable |
840,723,242.59 |
| Advances to Suppliers |
23,485,779.06 |
| Other Receivables |
8,705,184.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
827,443,936.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,655,844.53 |
| Total Current Assets |
2,496,130,475.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
211,326,312.75 |
| Investment Properties |
-- |
| Fixed Assetes |
754,228,299.75 |
| Under-construction Projects |
90,706,319.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
171,510,977.00 |
| R&D expenses |
-- |
| Goodwill |
176,805,593.29 |
| Long-Term Deferred and Prepaid Expenses |
12,816,275.90 |
| Deferred Income Tax Assets |
25,717,461.46 |
| Other Non-Current Assets |
69,002,051.43 |
| Sub-Total of Non-Current Assets |
1,607,868,446.30 |
| Total Assets |
4,103,998,921.82 |
| Short-Term Loans |
755,028,691.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
193,019,820.30 |
| Accounts Payable |
591,867,259.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,206,734.45 |
| Taxes Payable |
25,977,343.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,261,741.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,409,905.73 |
| Other Current Liabilities |
7,627,170.72 |
| Sub-Total of Current Liabilities |
1,722,135,400.83 |
| Long-term Loans |
113,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,191,564.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,372,143.36 |
| Total Liabilities |
1,904,507,544.19 |
| Paid-In Capital(Or Share Stock) |
490,799,306.00 |
| Capital Surplus |
784,063,420.91 |
| Surplus Reserve |
88,136,569.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
600,155,200.95 |
| Minority Stockholder's Interest |
238,451,648.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,961,039,729.02 |
| Owner's Equity（Stockholder's Equity） |
2,199,491,377.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,103,998,921.82 |
